Hos patienter med tidlig reumatoid artrit (sygdomsvarighed på mindre end 3 år) (forsøg 5) forekom forhøjede re ALAT- værdier oftere i kombinationsarmen (Trudexa/ methotrexat) end i methotrexat - monoterapiarmen eller Trudexa- monoterapiarmen. ge
In patients with early rheumatoid arthritis (disease duration of less than 3 years) (Study V), elevations of ALT were more common in the combination arm (Trudexa / methotrexate) compared to the methotrexate monotherapy